China Jo-Jo Drugstores, Inc.

NasdaqCM:CJJD Stock Report

Market Cap: US$5.2m

China Jo-Jo Drugstores Past Earnings Performance

Past criteria checks 0/6

China Jo-Jo Drugstoreshan disminuido a un ritmo medio anual de -562.2%, mientras que en la industria Consumer Retailing los ingresos han sido de growing a 13.9% anuales. Los ingresos han sido declining a una tasa media anual de 9.5%.

Key information

-20.7%

Earnings growth rate

26.1%

EPS growth rate

Consumer Retailing Industry Growth10.9%
Revenue growth rate9.6%
Return on equity-122.4%
Net Margin-13.9%
Last Earnings Update30 Sep 2023

Recent past performance updates

Recent updates

China Jo - Jo Drugstores GAAP EPS of -$0.92, revenue of $164.39M

Jul 28

China Jo-Jo Drugstores' (NASDAQ:CJJD) Stock Price Has Reduced 24% In The Past Five Years

Feb 09
China Jo-Jo Drugstores' (NASDAQ:CJJD) Stock Price Has Reduced 24% In The Past Five Years

China Jo-Jo Drugstores regains compliance with Nasdaq

Dec 23

China Jo - Jo Drugstores reports Q2 results

Nov 13

Revenue & Expenses Breakdown
Beta

How China Jo-Jo Drugstores makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqCM:CJJD Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 23155-21530
30 Jun 23152-21540
31 Mar 23149-21550
31 Dec 22154-12480
30 Sep 22159-4410
30 Jun 22162-3400
31 Mar 22164-3390
31 Dec 21157-2340
30 Sep 21150-7370
30 Jun 21141-8370
31 Mar 21133-8380
31 Dec 20128-11390
30 Sep 20126-4320
30 Jun 20123-4310
31 Mar 20117-6320
31 Dec 191130270
30 Sep 19111-2290
30 Jun 19110-2290
31 Mar 19108-1260
31 Dec 18105-17390
30 Sep 18101-17370
30 Jun 1897-16370
31 Mar 1896-17370
31 Dec 1792-9270
30 Sep 1786-8240
30 Jun 1782-7220
31 Mar 1781-6210
31 Dec 16820180
30 Sep 16860180
30 Jun 16890180
31 Mar 16890180
31 Dec 15891160
30 Sep 15862130
30 Jun 15821120
31 Mar 15771110
31 Dec 1472-16160
30 Sep 1469-24230
30 Jun 1467-25230
31 Mar 1466-25250
31 Dec 1364-20290
30 Sep 1362-15270
30 Jun 1372-16270

Beneficios de calidad: CJJD actualmente no es rentable.

Creciente margen de beneficios: CJJD actualmente no es rentable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Tendencia de beneficios: CJJD no es rentable, y las pérdidas han aumentado en los últimos 5 años a un ritmo de 20.7% al año.

Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de CJJD en el último año con su media de 5 años, ya que actualmente no es rentable.

Beneficios vs. Industria: CJJD no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el del sector Consumer Retailing (9.1%).


Return on Equity

Alto ROE: CJJD tiene un Rendimiento de los fondos propios negativo (-126.83%), ya que actualmente no es rentable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.